These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9092417)

  • 21. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
    Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract]   [Full Text] [Related]  

  • 22. [Medical therapy in peripheral arterial occlusive disease].
    Périard D; Hayoz D; Mazzolai L
    Rev Med Suisse; 2009 Feb; 5(189):312-5. PubMed ID: 19271648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Low molecular weight heparin in patients undergoing vascular surgery].
    Godet G; Kretz JG; Cristea T
    Ann Fr Anesth Reanim; 2005 Apr; 24(4):347-54. PubMed ID: 15826784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major arterial involvement and review of Behcet's disease.
    Alpagut U; Ugurlucan M; Dayioglu E
    Ann Vasc Surg; 2007 Mar; 21(2):232-9. PubMed ID: 17349371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic therapy in peripheral arterial disease.
    Lipsitz EC; Kim S
    Cardiol Clin; 2008 May; 26(2):289-98, vii. PubMed ID: 18407001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of surgical and thrombolytic treatment of peripheral arterial disease.
    Ouriel K
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S7-16. PubMed ID: 12556738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Conservative therapy of peripheral arterial occlusive disease].
    Frauchiger B
    Schweiz Rundsch Med Prax; 1990 Dec; 79(50):1560-3. PubMed ID: 2270377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic therapy in peripheral arterial occlusive disease.
    Jackson MR; Clagett GP
    Chest; 2001 Jan; 119(1 Suppl):283S-299S. PubMed ID: 11157655
    [No Abstract]   [Full Text] [Related]  

  • 30. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
    Cotter G; Cannon CP; McCabe CH; Michowitz Y; Kaluski E; Charlesworth A; Milo O; Bentley J; Blatt A; Krakover R; Zimlichman R; Reisin L; Marmor A; Lewis B; Vered Z; Caspi A; Braunwald E;
    Am Heart J; 2003 Apr; 145(4):622-7. PubMed ID: 12679757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antithrombotic drugs in peripheral arterial diseases].
    Verhaeghe R
    J Mal Vasc; 1983; 8(1):23-7. PubMed ID: 6221056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structured surveillance of patients with peripheral arterial occlusive disease after peripheral vascular interventions.
    Weiss N; Bergert H
    Vasa; 2009 Nov; 38(4):302-15. PubMed ID: 19998251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Even when walking yet does not cause any pain, peripheral arterial occlusive disease costs life years].
    MMW Fortschr Med; 2003 Apr; 145(15):63. PubMed ID: 15104272
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment strategies in arterial occlusive diseases].
    Bollinger A
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1354-8. PubMed ID: 8272701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis.
    Girolami B; Bernardi E; Prins MH; ten Cate JW; Prandoni P; Simioni P; Andreozzi GM; Girolami A; Büller HR
    Eur J Vasc Endovasc Surg; 2000 Apr; 19(4):370-80. PubMed ID: 10801370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
    Lange S; Diehm C; Darius H; Haberl R; Allenberg JR; Pittrow D; Schuster A; von Stritzky B; Tepohl G; Trampisch HJ
    Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):566-73. PubMed ID: 15578331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic antithrombotic therapy in post-myocardial infarction patients.
    Nagarakanti R; Sodhi S; Lee R; Ezekowitz M
    Cardiol Clin; 2008 May; 26(2):277-88, vii. PubMed ID: 18407000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral arterial procedures and postinterventional prophylaxis.
    Kröger K
    J Endovasc Ther; 2006 Feb; 13(1):32-8. PubMed ID: 16445321
    [No Abstract]   [Full Text] [Related]  

  • 39. [Risk factor control in peripheral arterial disease can be improved. Registry study of secondary prophylactic drug therapy].
    Alhadad A; Wiktorsson C; Lindblad B; Gottsäter A
    Lakartidningen; 2010 Sep 29-Oct 5; 107(39):2322-5. PubMed ID: 20973248
    [No Abstract]   [Full Text] [Related]  

  • 40. Is there a role for oral anticoagulant therapy in patients with peripheral arterial disease?
    Cosmi B; Palareti G
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):269-73. PubMed ID: 15379620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.